United States · Bill · S
S. 1062 (115th)
FDA Reporting Transparency and Accountability Act
Introduced
4 May 2017
Last action
—
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
—
Subjects
Discovery layer
Source updated
11 August 2025
Summary
FDA Reporting Transparency and Accountability Act This bill expands reporting requirements related to the performance of the Food and Drug Administration (FDA), including to require additional information on timeliness and personnel and publication every 30 days of information regarding FDA guidance and meetings.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 4 May 2017
Introduced in Senate (PDF)
Introduced in Senate · EN · 4 May 2017
Introduced in Senate
summary · EN · 4 May 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/senate-bill/1062
- Open data entity: https://api.congress.gov/v3/bill/115/s/1062